State-trait anxiety in methadone maintenance patients

Area of Science:

• Psychiatry
• Clinical Psychology
• Pharmacology

Background:

• Methadone maintenance treatment (MMT) is a cornerstone for opioid use disorder management.
• Anxiety is a common comorbidity in patients undergoing MMT, impacting treatment adherence and outcomes.
• Understanding the psychological effects of MMT, specifically on anxiety states and traits, is crucial for optimizing patient care.

Purpose of the Study:

• To investigate the longitudinal changes in anxiety-state (A-State) and anxiety-trait (A-Trait) among patients receiving methadone maintenance treatment.
• To determine if daily methadone administration influences immediate or sustained anxiety levels.
• To assess the impact of MMT over a six-month period on different facets of anxiety.

Main Methods:

• Prospective study design involving patients undergoing methadone maintenance treatment.
• Assessment of A-State and A-Trait using validated psychometric instruments at baseline and regular intervals over six months.
• Statistical analysis to compare anxiety measures before and after methadone administration and over the study duration.

Main Results:

• A significant reduction in A-State was observed following the daily dosage of methadone.
• No significant changes were detected in A-Trait levels throughout the six-month assessment period.
• The findings suggest methadone's anxiolytic effect is primarily on state anxiety rather than trait anxiety.

Conclusions:

• Methadone maintenance treatment effectively reduces state anxiety in patients with opioid use disorder.
• Trait anxiety, representing a more stable personality characteristic, appears unaffected by MMT in this cohort.
• These findings highlight the specific psychological benefits of methadone in managing acute anxiety symptoms within MMT.